When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GRX - Malaria drug fails to show benefit in COVID-19 study
The Gabelli Healthcare & Wellness Trust of Beneficial Interest
An observational study involving COVID-19 patients treated at New York-Presbyterian Hospital-Columbia University Irving Medical Center did not show a treatment benefit from the use of malaria drug hydroxychloroquine. The results were just published in the New England Journal of Medicine.
More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellness Rx Trust, Healthcare stocks news, News on ETFs,